Modified FOLFIRINOX versus CISGEM as first-line chemotherapy for advanced biliary tract cancer: Results of AMEBICA PRODIGE 38 randomized phase II trial

Phelip, JM; Desrame, J; Edeline, J; Barbier, E; Terrebonne, E; Michel, P; Perrier, H; Dahan, L; Bourgeois, V; Akouz, FK; Soularue, E; Lebrun, VL; Molin, Y; Lecomte, T; Ghiringhelli, F; Coriat, R; Louafi, S; Neuzillet, C; Manfredi, S; Malka, D

ANNALS OF ONCOLOGY, 2020; 31 (): S260